Background: Case reports of inflammatory bowel diseases [IBD] have been reported in patients with a history of bariatric surgery. Our aim was to characterize patients who were diagnosed with IBD after having undergone bariatric surgery. Methods: Electronic medical records were reviewed at two institutions to identify patients who developed de-novo Crohn's disease or ulcerative colitis [UC] after bariatric surgery. Data on demographics, type of bariatric surgical procedure, IBD subtype, phenotype and medication usage were obtained. The incidence rate of de-novo IBD after bariatric surgery [per 100 000 personyears] and standardized incidence ratio [SIR] were estimated from a prospective bariatric surgery database. Results: A total of 44 patients with de-novo IBD after bariatric surgery were identified [31 Crohn's disease, 12 UC, one IBD unclassified]. Most patients were female [88.6%], with median age at IBD onset of 44 years [IQR, [37] [38] [39] [40][41][42][43][44][45][46][47][48][49][50][51][52] and median time to IBD diagnosis after bariatric surgery of 7 years [IQR, [3] [4] [5] [6] [7] [8] [9] [10] . Sixty-eight per cent underwent Roux-en-Y gastric bypass. In the prospective database, the incidence of IBD in patients who underwent bariatric surgery was 26.7 per 100 000 person-years [4.5 for UC and 22.3 for Crohn's disease]. The age-adjusted SIR ranged from 3.56 in the 40-49 year age group to 4.73 in the 30-39 year age group. Conclusion: We described a case series of patients developing de-novo IBD after bariatric surgery. There appears to be a numerically higher incidence of Crohn's disease in this population. Confirmation of causality is required in larger patient cohorts.
Introduction
Obesity is a major healthcare problem worldwide and is thought to affect approximately 266 million men and 375 million women and its incidence and prevalence continue to rise. 1 Bariatric surgery is an effective treatment option and may be indicated in severe obesity or when comorbidities are present. In the United States, over 100 000 bariatric surgeries are performed annually. 2 The most common bariatric surgical procedures are Roux-en-Y gastric bypass [RYGB] and sleeve gastrectomy. 3 Known adverse gastrointestinal effects of a surgical approach, especially with restrictive and malabsorptive procedures such as RYGB, include vitamin deficiency, abdominal pain and diarrhoea. 4 In addition, a major shift in the microbiome of the gastrointestinal tract after bariatric surgery has been reported, with a decrease in the ratio of Firmicutes to Bacteroidetes. 5, 6 Recent small case reports have described de-novo inflammatory bowel disease [IBD] following bariatric surgery. [7] [8] [9] There are no available data regarding the incidence of Crohn's disease or ulcerative colitis [UC] in patients who underwent recent bariatric surgery for obesity.
The aim of this study was to describe the occurrence of de-novo IBD from two tertiary referral centres following bariatric surgery and determine the incidence of Crohn's disease and UC in that population group.
Methods
Electronic medical records from January 1, 1996 to December 31, 2016 were reviewed using informatics search tools at two institutions [Mayo Clinic, Rochester, MN, USA; and Washington University School of Medicine, St Louis, MO, USA] to identify patients with co-occurrence of an ICD-9/10 code for Crohn's disease or UC and clinical note terms associated with bariatric surgery [RYGB, bariatric surgery, gastroplasty, gastric bypass, gastric sleeve, duodenal switch, gastric banding]. Separate approval was obtained at both institutions from the Institutional Review Board prior to the conduct of research. Data on demographics, type of bariatric surgical procedure, Crohn's disease or UC disease phenotype, and medication usage were obtained. Patient charts were manually reviewed for symptoms and previous IBD diagnosis. We additionally performed a search for prior reports [full manuscript or abstract] for de-novo IBD after bariatric surgery by searching PUBMED using MESH terms 'Inflammatory Bowel Diseases' and 'Bariatric Surgery' separated by Boolean operator 'AND' from 1946 to the present. The reference lists of identified articles were hand-searched to identify other case reports. Additionally, abstracts from the previous 5 years [2012] [2013] [2014] [2015] [2016] [2017] at the Digestive Diseases Week, Annual Scientific Meeting of the American College of Gastroenterology, Advances in IBD meeting, United European Gastroenterology Week and European Crohn's and Colitis Organization were examined.
A prospectively maintained 20-year database on all bariatric surgery cases was available at one institution [Mayo Clinic, Rochester] and used to calculate person-years incidence of de-novo IBD in that population. Total time of follow-up was calculated starting from the time of bariatric surgery until last known follow-up. The last followup date was defined as the last date a patient was seen by a provider [physician, physician assistant or nurse practitioner]. Follow-up time was truncated at December 31, 2016. Total person-years of follow-up across age categories and sex were used to calculate incidence [cases per 100 000 person-years]. The standardized incidence ratio [SIR, observed divided by expected] of Crohn's disease was estimated. The expected number was derived using age-and sex-adjusted incidence rates of Crohn's disease in Olmsted County, Minnesota as a reference standard. . Most patients were evaluated for IBD due to ongoing symptoms, which generally included abdominal pain and/or diarrhoea. Two patients with Crohn's disease were incidentally diagnosed. One patient was undergoing work-up for chronic anaemia and underwent abdominal computed enterography, while the other patient was being worked-up for symptomatic gastroesophageal reflux disease and underwent barium follow through test.
Results

Patient demographics
IBD subtype, location and phenotype
Among the patients with Crohn's disease [ Table 2 ]. IBD-associated surgery was performed in ten patients [22.7%] . The most common IBD-related surgery in the Crohn's disease group was ileostomy and fistulectomy, while in the UC group, one patient underwent ileostomy and proctocolectomy.
Review of cases in the literature
As illustrated in Table 3 
Discussion
In Obesity has become a worldwide epidemic, affecting approximately 650 million people. The prevalence and incidence of obesity has increased dramatically in the last few decades and current trends show that 18% of men and 21% of women may be obese globally by 2025. 1 Treatment options include lifestyle modification, weight-loss pharmacotherapy or a surgical approach. In the United States, the incidence of bariatric surgery has plateaued at approximately 113 000 per year, with the majority of those procedures performed in women. 2 The relationship between obesity, bariatric surgery and IBD is not yet fully understood. This dynamic has gathered interest as the prevalence and incidence of obesity in patients with IBD as well as in the general population continue to rise. 16 It has been reported that approximately 15-40% of adults with IBD are obese. 17, 18 Obesity is considered a chronic low-grade inflammatory process mediated by pro-inflammatory cytokines, such as TNF-α and interleukin-6 [IL-6], as well as adipokines such as leptin and resistin secreted by adipocytes or macrophages. Although obesity has been associated with increased disease activity of several autoimmune conditions such as rheumatoid arthritis and psoriasis, this association has not been consistently demonstrated in IBD. 19, 20 An increased risk of incident Crohn's disease with pre-morbid obesity has been shown in some studies but not in others while no association has been shown between obesity and UC. [21] [22] [23] [24] [25] Small case reports of de-novo IBD following bariatric surgery have been reported, suggesting that perhaps the surgical procedure could trigger the development of IBD in a genetically predisposed individual. The first case report was published in 1999 by Papakonstatinous et al., and described a young male who underwent vertical banded gastroplasty for obesity and was diagnosed 3 months later with UC after new-onset persistent diarrhoea, abdominal pain and anaemia. Subsequently, Ahn et al. described three female patients who underwent RYGB for obesity and were later diagnosed with Crohn's disease in the setting of persistent diarrhoea and abdominal pain. Recently, two cases of de-novo Crohn's disease following RYGB were reported. 13 Finally, a retrospective chart review study from Austria described six patients with de-novo Crohn's disease following bariatric surgery. 14 It remains unclear if a true association between bariatric surgery and development of IBD exists. The incidence rate of Crohn's disease [22. 3 cases per 100 000 person-years] was numerically higher than the overall age-and sex-adjusted annual incidence rate of Crohn's disease in the United States [8.7 cases per 100 000 personyears] while the incidence rate of UC was numerically lower than the age-and sex-adjusted annual rate in the United states [4.5 vs 10.7 per 100 000 person-years]. 10 Furthermore, the age-and gender-adjusted incidence rate was higher [SIR 3.3-7.1] than the reference population-based incidence rates from Olmsted County [1970-2010 data] . In another retrospective case-control study using a national healthcare insurance claims database including 8968 cases and 42 929 controls, a past history of bariatric surgery was associated with an increased risk of de-novo IBD. 26 The risk was increased for both UC (odds ratio [ It has been recently suggested that early-onset and late-onset de-novo IBD following bariatric surgery may have different mechanisms. In early-onset disease, loss of the stomach's defences may expose the intestine to different toxins and chemicals, while in lateonset disease, rapid weight loss may lead to release of inflammatory cytokines by adipose tissue or major anatomical alteration caused by surgery may lead to bacterial overgrowth and change in the microbiome. 15 Several studies have shown that the greatest reduction of BMI following bariatric surgery occurs within 1 year after procedure [Douglas et al., 2015] . The median overall latency period in our study [time from bariatric surgery to the development of IBD] was 7.5 years. Interestingly, in the study by Ungaro et al., the risk of IBD [both Crohn's disease and UC] was increased after 4 years from bariatric surgery, but not within this time period. 26 This latency could be more consistent with the microbiome hypothesis.
The pathogenesis of IBD is complex. 27 While genetic and immunological factors play a major role, the microbiome has also been implicated. 28 Patients with IBD have dysbiosis of gut microbiota when compared to healthy individuals, and this difference is thought to be greater in patients with Crohn's disease than UC. [29] [30] [31] Patients with Crohn's disease have been shown to have overall decreased intestinal microbiome diversity, with a decrease in Bacteroidetes and Firmicutes and increase in Proteobacteria and Actinomycetes. 32 A recent study involving 13 morbidly obese patients evaluated the gastrointestinal microbiome before, at 3 months after and at 12 months after RYGB, and found an increase microbial diversity at 3 months, which persisted at 1 year. 33 Although this may seem paradoxical, phylum analysis showed a significant increase in Proteobacteria and non-significant increase in Actinomyces, while there was a non-significant decrease in Bacteroidetes, which is somewhat similar to what has been described in Crohn's disease.
In contrast to what had been previously described in the literature, we also report patients who developed UC following bariatric surgery, highlighting that this phenomenon may not be linked exclusively to development of Crohn's disease. In the United States, the prevalence of Crohn's disease and UC in the general population is approximately 201 and 238 per 100 000 adults, respectively. 34 The higher ratio of 2.6 cases of Crohn's disease to every case of UC found in our study and previous reports may be at least partially explained by the predominance of female gender in our population, which is consistent with notion that there is a slight predominance of female gender distribution in Crohn's disease. [35] [36] [37] Alternatively, as previously mentioned, the impact of dysbiosis of the gastrointestinal flora may be greater in patients with Crohn's disease. Finally, the higher proportion of female patients found in our study population [88.6%] is also consistent with large epidemiological studies that show a female preponderance [83%] among patients who undergo bariatric surgery. 38 In our study population of de-novo IBD after bariatric surgery, a milder phenotype is reported in which only 8.3% of patients with UC and 28.5% of those with Crohn's disease underwent an IBD-related surgical procedure during a median follow-up time of 11 years from time of IBD diagnosis. In comparison at 10 years after diagnosis, the overall rates of surgery have been reported to range from 2.8 to 24% in UC and 37 to 61% in Crohn's disease. 39 Regarding family history of IBD, our study is in agreement with previous case reports which found a low percentage of cases with a positive family history. 13 The limitations of the study include the retrospective design of the study, including cross-referencing disease codes, which may result in selection bias. However, the long latency of onset of IBD limits the feasibility of a prospective study design. Other limitations include a possible referral bias with case finding in two tertiary IBD centres which may have led to an overestimation of the true incidence of denovo IBD after bariatric surgery. At the same time, many patients may associate diarrhoea and other gastrointestinal symptoms as normal post-operative symptoms leading to an underestimation of the true incidence of de-novo IBD after bariatric surgeries. In addition, our study could not account for the possibility of obesity having increased the risk of IBD in our study population in the absence of a comparator group of prospectively enrolled control group of obese patients who did not undergo bariatric surgery. There was a high prevalence of smoking in our study [31.8%] , which may have contributed to the higher incidence of CD found. The use of person-years incidence rate in our study in another limitation, as by using this strategy one assumes that there is a constant cumulative incidence rate, and the surgical procedure may have had greater impact on incidence during specific time-points. Finally, the current study also has a modest sample size of 44 patients but which is larger than the 16 patients reported across all prior case reports of this condition.
In conclusion, IBD should be considered in the differential diagnosis of delayed onset of worsening diarrhoea or new/worsening abdominal pain in patients with a history of bariatric surgery. A numerically higher incidence rate of Crohn's disease was found in our patient population, although larger prospective studies with linked microbiome analysis are needed to determine causality.
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